<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: In Praise of Universal Coverage From a Genomics Perspective</title>
	<atom:link href="http://crossborderbiotech.ca/2009/09/30/in-praise-of-universal-coverage-from-a-fan-of-personalized-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>http://crossborderbiotech.ca/2009/09/30/in-praise-of-universal-coverage-from-a-fan-of-personalized-medicine/</link>
	<description>Biotechnology, Health and Business in Canada, the United States and Worldwide</description>
	<lastBuildDate>Tue, 09 Mar 2010 06:05:34 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Disclosure of Patients’ Genetic Information Without Their Consent&#8211;Is the “Public Interest” Really a Sufficient Justification?</title>
		<link>http://crossborderbiotech.ca/2009/09/30/in-praise-of-universal-coverage-from-a-fan-of-personalized-medicine/comment-page-1/#comment-1077</link>
		<dc:creator>Disclosure of Patients’ Genetic Information Without Their Consent&#8211;Is the “Public Interest” Really a Sufficient Justification?</dc:creator>
		<pubDate>Tue, 10 Nov 2009 12:32:24 +0000</pubDate>
		<guid isPermaLink="false">http://crossborderbiotech.ca/?p=3271#comment-1077</guid>
		<description>[...] suggested that the difference can be traced to the presence of universal healthcare in the U.K. (“In Praise of Universal Coverage From a Genomics Perspective”). Particularly in the U.S., a major impetus for protecting the confidentiality of genetic [...]</description>
		<content:encoded><![CDATA[<p>[...] suggested that the difference can be traced to the presence of universal healthcare in the U.K. (“In Praise of Universal Coverage From a Genomics Perspective”). Particularly in the U.S., a major impetus for protecting the confidentiality of genetic [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: PolITiGenomics &#187; Blog Archive &#187; What ELSI is New?</title>
		<link>http://crossborderbiotech.ca/2009/09/30/in-praise-of-universal-coverage-from-a-fan-of-personalized-medicine/comment-page-1/#comment-996</link>
		<dc:creator>PolITiGenomics &#187; Blog Archive &#187; What ELSI is New?</dc:creator>
		<pubDate>Wed, 07 Oct 2009 14:09:15 +0000</pubDate>
		<guid isPermaLink="false">http://crossborderbiotech.ca/?p=3271#comment-996</guid>
		<description>[...] the record, while this opinion piece was just published, I did write it before this similar piece [...]</description>
		<content:encoded><![CDATA[<p>[...] the record, while this opinion piece was just published, I did write it before this similar piece [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
